BristolMyers Squibb fighting off investor protests of its planned merger with Celgene has won over the most influential advisers on Wall Street improving the companys odds of pulling off the $74 billion deal. httpsbuff.ly2JRwQmRÂ

Bristol-Myers Squibb, fighting off investor protests of its planned merger with Celgene, has won over the most influential advisers on Wall Street, improving the company’s odds of pulling off the $74 billion deal. https://buff.ly/2JRwQmR 

Bristol-Myers Squibb, fighting off investor protests of its planned merger with Celgene, has won over the most influential advisers on Wall Street, improving the company’s odds of pulling off the $74 billion deal. https://buff.ly/2JRwQmR 

More From BioPortfolio on "Bristol-Myers Squibb, fighting off investor protests of its planned merger with Celgene, has won over the most influential advisers on Wall Street, improving the company’s odds of pulling off the $74 billion deal. https://buff.ly/2JRwQmR "